outlook leav littl margin error maintain market perform
view still concern multipl pressur point
across kmb busi incl elev input cost
fx headwind encourag price support
better-than-expect organ sale growth remain
kmb histor trend recent result peer
pg concern margin pressur
gross/ebit margin y/i despit
increasingli ration promot environ although
new ceo mike hsu rebas expect initi ep
guidanc well estimate print
provid conserv outlook org sale growth
 msd ep growth concern upsid like
competit dynam what given pressur
wonder there realli lot room management execut
emerg market growth incr e-comm/digit market spend
all-in remain sidelin lower ep est
said believ signific
downsid share limit expect
rebas maintain price target
product
ep disappoint weak margin kmb adj ep
y/i estimate /con kmb
organ sale growth better-than-expect
our/street est driven north america
na consum product organ sale growth signific
sequenti improv vs organ sale
growth also sequenti improv
said price solid volume growth remain
mute flat y/i furthermor ebit remain weak adj
ebit margin y/i incl consum tissu
y/i focus reduc cost
everywher off-set higher input cost
given somewhat challeng backdrop
surpris initi ep guidanc mid-
point impli flat y/i earn growth what
encourag management expect organ net sale growth
reflect higher net sell price least
mind like lumpi throughout
year lap promo
china trend still weak concern weak low
teen org sale growth china larg reflect
continu price competit management optimist
kmb innov pipelin health market
increasingli concern kmb abil execut china
particularli time peer pg gener robust
mid-teen organ sale growth short kmb new k-c
strategi increas focu market china
wonder enough littl late
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani data secur llc estim reuter
ep expect report ep y/i
our/consensu estim
kmb organ sale ahead expect organ sale growth our/street
est north america na consum product solid y/i develop
emerg de market organ sale growth segment organ sale growth
follow vs estimate consum tissu vs estimate
k-c profession vs estimate
exhibit organ sale trend segment
organ sale growth ahead estim all-in sale
declin chang fx headwind net sell price volum
favor product mix oper profit howev disappoint
 reflect among thing input cost inflat unfavor currenc effect
increas market research gener spend north america sale primarili
due higher volum msd infant child care categori driven growth
pull-up train pant goodnit youth pant volum also msd adult care led
depend product sale develop market outsid north america australia south korea
western/centr europ includ neg impact chang currenc
rate net sell price declin sale develop emerg market
disappoint larg reflect fx headwind net sell price
product mix improv volum howev declin higher net sell price primarili
latin america secondarili east/eastern europe/africa partial
off-set decreas china continu disappoint lower volum reflect declin china
argentina partial off-set increas asean eastern europ
consum tissu organ sale growth estim sale
essenti even y/i consum tissu all-in chang fx reduc sale around net sell
price solid volum disappoint product mix
slightli oper profit howev disappoint reflect input cost
inflat lower volum higher market cost research gener spend
manufactur cost increas partial off-set benefit increas net sell
price cost save north america sale net sell price reflect
price increas lower promot activ volum disappoint product
mix sale develop market outsid north america chang
fx reduc sale net sell price volum product mix
develop emerg market sale decreas currenc rate
headwind mostli latin america net sell price product mix improv
k-c profession organ sale growth vs estim sale
chang fx reduc sale overal net sell price volum
solid product mix improv oper profit howev reflect
input cost inflat unfavor currenc effect mostli off-set organ sale growth cost
save north america sale volum reflect increas
washroom safeti product net sell price product mix
develop market outsid north america sale y/i fx headwind unfavor
net sell price product mix improv volum howev declin
develop emerg market sale decreas includ impact fx
net sell price volum product mix
k-c strategi reset kmb near-term object addit report
earn introduc new k-c strategi manag hope enabl
deliv balanc sustain growth creat sharehold valu assum
continu challeng environ object associ program includ sale
growth in-lin slightli ahead categori growth rate hope elev
core busi acceler growth market drive digit market e-comm sale
support object intend focu launch differenti product innov
drive categori develop leverag commerci capabl sale market
gener save turn fund growth initi improv margin manag
call sever key focu area support stepped-up save includ drive on-going suppli
chain product improv program continu execut
global restructur program rigor control discretionari spend sustain
overhead cost structur drive improv work capit expect capit
spend annual rate net sale complet global restructur
program addit broader strategi also introduc new medium-term financi
object manag believ adequ reflect modest on-going categori growth
includ sale organ sale growth annual adjust ep growth msd
adjust least in-lin current level dividend growth
gener line adjust ep growth
initi guidanc set bar reflect think remain tough
oper environ surpris compani new ceo mike hsu rebas
expect set conserv bar first full year ceo
includ net sale declin unfavor fx rate
busi exit conjunct global restructur program expect
reduc sale slightli mostli k-c profession increas organ sale growth
driven higher net sell price least adjust oper profit growth
save incl program million
global restructur program inflat key cost input million
manag expect major inflat occur intern market foreign
currenc translat headwind higher y/i interest expens adjust
effect tax rate vs percent manag note mid-
point higher rate repres reduct adjust ep net incom equiti
compani similar y/i adjust ep vs capital-expenditure
includ signific spend relat global restructur program
dividend increas quarterli dividend per share per share
share repurchas said think rebas expect
doabl remain concern recent price action may fulli off-set persist structur
headwind incl higher privat label penetr elev commod cost
volum average price/unit growth y/i
dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
organ sale develop emerg market organ sale longer track deliv consist highsingl low-doubl digit organ growth believ could continu weigh investor sentiment -particularli trend deterior sale y/yavg eq price y/ydollar sale y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end channel data chang bp dollar share corpor
note total organ sale growth data includ segment includ kc-profession across
geographi compani report nielsen xaoc includ c-store secur llc estim
note total person organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
note total consum tissu organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
exhibit categori result period end categori retail sale
note babi diaper china breakdown cover nielsen mass retail univers total china nation exclud
babi store babi diaper specialti breakdown babi store jf january/februari
nielsen scantrack total emerg market secur llc
exhibit emerg market valu sale volum average price per growth
nielsen scantrack total emerg market secur llc
exhibit emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
exhibit european summari data week end
european eq volum average price/eq growth
european valu share y/i chang
chart tabl nielsen esp total europ secur llc
exhibit guidanc medium-term outlook
volum sale y/yavg price per eq y/yvalu sale y/yvalu shareeq volum shareperiod end end end end end volumesavg price per eq valu sale chang bp valu sharey/i chang bp valu sharek-c strategi medium term objectivesour est growthup sale growthup line ep provid januari call fy sale sale impact impact profitsadj op profit growth ex-charg allocationcapit total capit allocationshar repurchas share repurchas dividend itemsinput pulp per metric ton oil per barrel save global restructur interest expenseincreas somewhat vs vs incom equiti companiessimilar vs vs lycash vs vs lyfi guidanc cosmet household person
guidanc provid januari call april call juli call oct call fy sale sale py/up slightli y/yslightli higher previous assumedmodestli posit posit impact salesneutr impact sale profitsadj op profit high end slightli growth ex-charg allocationcapit total capit allocationshar repurchas share repurchas defin benefit pension contributionsdividend itemsinput half rang pulp per metric y/yoil per y/ysav global restructur interest vs low incom equiti companiessimilar slightli vs lycash vs lyfi guidanc corpor
one largest consum product compani world strong portfolio highli
recogniz brand kleenex scott huggi pull-up kotex depend given strong
foothold mani key develop emerg market believ well posit capit
long-term expans growth spend power global middl class addit
optimist benefit long-term growth tailwind key categori adult
incontin matur develop market like unit state well emerg market
china continu gener cost save introduc greater level effici across
global oper particularli within suppli chain expect continu work
supplier upstream innov develop product value-accret compani
end user simultan lower input cost howev pressur mount kmb near-
term growth opportun given difficult price environ intensifi competit weaker
categori growth sever key market convict kmb emerg market
growth like rebound long term expect near-term emerg market growth remain
challeng bottom line time recoveri emerg market growth
uncertain believ prudent investor remain sidelin
price target base follow methodolog forward ev-to-ebitda price-to-earnings
analysi absolut rel discount analysi
forward ev-to-ebitda absolut rel current trade
ev/ebitda multipl premium compani histor averag
multipl discount compani histor averag multipl
price target impli ev/ebitda multipl discount
compani current ev/ebitda multipl discount histor averag multipl
discount histor averag multipl furthermor current trade
discount rel hpc peer group forward ev/ebitda multipl basi compar
discount hpc group histor averag forward ev/ebitda basi
discount hpc group histor averag forward ev/ebitda basi
forward price-to-earnings absolut rel current trade price-to-earnings multipl
premium compani histor averag multipl
discount compani histor averag multipl price target impli
price-to-earnings multipl discount compani current price-to-earnings multipl
premium histor averag multipl discount histor
averag multipl furthermor current trade discount rel hpc peer
group forward price-to-earnings multipl basi compar discount hpc group
year histor averag forward price-to-earnings basi discount hpc group histor
sum-of-the-part discount also valu base sum-of-the-part dcf
analysi better understand compani growth opportun particularli person
k-c profession base analysi believ worth
segment worth consum tissu segment worth k-c
chart factset secur llc
chart factset secur llc
multipl pt spreadabsolut performancerel perform spreadwidest posit spread neg spread ntm stapl spreadwidest posit spread neg spread rel yr rel rel consum stapl pt spread rel yr pt spread rel pt spread rel consum stapl
chart factset secur llc
multipl pt spreadabsolut performancerel perform spreadwidest posit spread neg spread ev/ebitda stapl spreadwidest posit spread neg spread rel yr rel rel consum stapl pt spread rel yr pt spread rel pt spread rel consum stapl cosmet household person
compani report secur llc estim
good sold- profit- research a- incom expens net- income- income- taxes- rate- equiti interests- net incom equiti companies- interest- income- eps- per net tissu net profession net sale ex research incom ex currenc incom k-c ep ex corpor
compani report secur llc estim
revenu build unless l/c sale profession sale ex-curr net sale incom total segment oper incom expens net- oper ex-charg sale growth sale growth ex-curr incom growth total segment oper net sale excl interseg incom segment oper incom segment oper margin cosmet household
exhibit privat label retail share across hpc weight lead brand hpc compani
note unilev hpc exclud unilev food categori analysi base retail share across track
channel
compani report nielsen total us xaoc includ conveni databas secur llc
changespot pricepricesappear changespot pricepricesappear hpcweightedaverageweightedaverag ex pg weight privat label share trail week changeunchangeddecreaseincreasedecreaseincreaseincreaseincreaseincreasedecreaseincreas corpor
price target nc
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ heighten competit pressur stronger dollar commod price volatil
strong develop emerg market footprint appear well posit capit long-
term expans spend power global rise middl class howev emerg market
categori growth moder competit pressur intensifi cautiou near term
base dalla tx one largest consum product compani world
lead brand kleenex scott huggi pull-up kotex depend hold
share posit countri sale
busi year sell brand countri
